| Overall population (n = 530) | Living (n = 366) | Deceased (n = 164) | p value |
---|---|---|---|---|
Demographics | ||||
Age (years) | 69 ± 15 | 68 ± 15 | 73 ± 14 | < 10− 3 |
Male gender | 341 (64%) | 243 (66%) | 98 (60%) | 0.141 |
BMI (kg.m− 2) | 27.8 ± 37.5 | 29.3 ± 44.9 | 24.3 ± 6.2 | 0.038 |
Hypertension | 230 (43%) | 159 (43%) | 71 (43%) | 0.974 |
Chronic cardiac failure | 134 (25%) | 74 (20%) | 60 (37%) | < 10− 3 |
Coronary heart failure | 104 (20%) | 64 (17%) | 40 (24%) | 0.065 |
Diabetes Mellitus | 151 (28%) | 109 (30%) | 42 (26%) | 0.326 |
Cancer history | 186 (35%) | 116 (32%) | 70 (43%) | 0.015 |
COPD | 79 (15%) | 49 (13%) | 30 (18%) | 0.144 |
Chronic Renal Failure | 75 (14%) | 45 (12%) | 30 (18%) | 0.069 |
Immunosuppression | 189 (36%) | 120 (33%) | 69 (42%) | 0.040 |
Prehospital | ||||
Initial SBP (mmHg) | 97 ± 30 | 99 ± 30 | 93 ± 30 | 0.056 |
Initial DBP (mmHg) | 58 ± 19 | 59 ± 19 | 55 ± 20 | 0.069 |
iPP (mmHg) | 39 ± 17 | 40 ± 17 | 38 ± 18 | 0.200 |
iPP < 40mmHg | 292 (55%) | 198 (54%) | 94 (57%) | 0.491 |
Initial MAP (mmHg) | 71 ± 22 | 72 ± 22 | 68 ± 22 | 0.064 |
Initial HR (beats.min− 1) | 114 ± 28 | 115 ± 28 | 113 ± 31 | 0.463 |
Initial RR (movements.min− 1) | 30 [22–36] | 28 [22–35] | 31 [25–38] | 0.007 |
Initial pulse oximetry (%) | 92 [85–96] | 93 [87–96] | 90 [83–95] | 0.006 |
Initial body core temperature (°C) | 38.3 [36.5–39.1] | 38.4 [36.8–39.3] | 38.1 [36.0–39.0] | 0.018 |
Initial Glasgow coma scale | 15 [12–15] | 15 [13–15] | 14 [11–15] | 0.002 |
Initial blood lactate (mmol.l− 1) | 5.8 ± 3.4 | 5.7 ± 3.3 | 6.3 ± 3.6 | 0.071 |
Fluid expansion (ml) | 750 [500–100] | 750 [500–1000] | 750 [500–1000] | 0.523 |
Norepinephrine administration | 155 (29%) | 104 (28%) | 51 (31%) | 0.530 |
Prehospital AB administration | 132 (25%) | 97 (27%) | 35 (21%) | 0.205 |
Prehospital duration (min) | 71 ± 34 | 69 ± 33 | 74 ± 35 | 0.111 |
Final SBP (mmHg) | 106 ± 25 | 109 ± 25 | 100 ± 24 | < 10− 3 |
Final DBP (mmHg) | 62 ± 18 | 63 ± 18 | 60 ± 10 | 0.058 |
dPP (mmHg.min− 1) | 0.07 ± 0.39 | 0.08 ± 0.39 | 0.02 ± 0.41 | 0.100 |
Final MAP (mmHg) | 77 ± 19 | 78 ± 19 | 74 ± 19 | 0.040 |
Final HR (beats.min− 1) | 107 ± 25 | 107 ± 25 | 109 ± 25 | 0.396 |
Final RR (movements.min− 1) | 25 [19–30] | 24 [18–30] | 26 [20–34] | 0.011 |
Final pulse oximetry (%) | 97 [94–99] | 97 [95–99] | 97 [93–98] | < 10− 3 |
Final body core temperature (°C) | 38.1 [36.2–39.3] | 38.0 [36.9–39.1] | 38.9 [35.9–39.6] | 0.041 |
Final Glasgow coma scale | 15 [14–15] | 15 [14–15] | 14 [12–15] | < 10− 3 |
Final blood lactate (mmol.l− 1) | 4.2 ± 3.3 | 3.5 ± 2.8 | 5.7 ± 3.8 | < 10− 3 |
Hospital | ||||
SOFA score | 6 [3–9] | 5 [3–8] | 7 [4–10] | < 10− 3 |
In-ICU length of stay (days) | 4 [2–8] | 4 [2–9] | 3 [1–7] | 0.007 |
In-hospital length of stay (days) | 10 [5–18] | 13 [8–21] | 5 [2–11] | < 10− 3 |